Tolebrutinib

产品说明书

Print
Chemical Structure| 1971920-73-6 同义名 : SAR442168;PRN2246
CAS号 : 1971920-73-6
货号 : A1372178
分子式 : C26H25N5O3
纯度 : 97%
分子量 : 455.508
MDL号 : MFCD32710277
存储条件:

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(230.51 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Tolebrutinib, also known as SAR442168, is a potent, selective, orally active and brain-penetrating BTK inhibitor with IC50 values of 0.4 nM and 0.7 nM in Ramos B cells and HMC microglia cells, respectively.Tolebrutinib has shown efficacy against CNS immunity. Tolebrutinib is used in multiple sclerosis (MS) studies[1][2].Tolebrutinib blocks BCR-mediated immune cell activation (IC50=10 nM) and Fc receptor activation (IC50 of 166 and 9.6 nM for FcεR and FcγR, respectively)[2].PRN2246 inhibits microglia FcγR activation through persistent BTK occupancy with an IC50 value of 157 nM[2].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.20mL

0.44mL

0.22mL

10.98mL

2.20mL

1.10mL

21.95mL

4.39mL

2.20mL

参考文献

[1]Dahl K, et, al. Radiosynthesis of a Bruton's tyrosine kinase inhibitor, [ 11 C]Tolebrutinib, via palladium-NiXantphos-mediated carbonylation. J Labelled Comp Radiopharm. 2020 Sep;63(11):482-487.

[2]Francesco MR, et, al. PRN2246, a potent and selective blood brain barrier penetrating BTK inhibitor, exhibits efficacy in central nervous system immunity. Multiple Sclerosis Journal. 2017;Poster Session 2:P989.